Stocks / Stock overview
Trulieve Cannabis Corp. (TRLV)
$11.82+7.16%Aft $11.76 (-0.50%)Market cap $2.28B
NYSE · Price as of · Nasdaq Real Time Price
Stock Scorer
Scoring…
Analyst consensus
$18.18
- Analysts7
- Implied upside+53.8%
- Target range$15.00 to $21.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
before the open
- EPS expected$0.07
- A year ago-$0.07
- Revenue expected$221.9M -23%
- Estimate range$0.02 to $0.12
Consensus of 2 analysts for the quarter ending September 30, 2026. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar
SEC filings
| Form | Filed | Description |
|---|---|---|
| S-8 POS | August 24, 2026 | S-8 POS |
| POSASR | August 24, 2026 | POSASR |
| 8-K | August 11, 2026 | 8-K |
| 10-Q | August 7, 2026 | 10-Q |
| 8-K | August 7, 2026 | 8-K |
| 8-K | August 5, 2026 | 8-K |
| SCHEDULE 13G | July 8, 2026 | View on EDGAR |
| 8-K | July 2, 2026 | 8-K |
Frequently asked questions
When does TRLV report earnings?
Trulieve Cannabis Corp. (TRLV) is scheduled to report quarterly results on November 5, 2026, before the open. The 2-analyst consensus is $0.07 per share on revenue of $221.9M for the quarter ending September 30, 2026, against -$0.07 and $288.2M a year earlier.
What do analysts expect for TRLV?
7 analysts cover Trulieve Cannabis Corp. (TRLV). The consensus rating is Strong buy. The average price target is $18.18, in a range of $15.00 to $21.00.
Are insiders buying or selling TRLV?
We have no qualifying Form 4 insider purchases or sales on record for Trulieve Cannabis Corp. (TRLV). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see TRLV SEC filings?
Recent filings are listed on this page, newest first. The latest is an S-8 POS filed August 24, 2026.
Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.